Skip to main content

Tactile Systems Technology, Inc.

corporate_fare Company Profile

Tactile Systems Technology, Inc.

TCMD·NASDAQ·Industrial Applications And Services·CIK 0001027838

Tactile Systems Technology, Inc. (doing business as "Tactile Medical" since September 2013) is a medical technology company that develops and provides medical devices for the treatment of underserved chronic diseases. The company was originally incorporated in Minnesota on January 30, 1995, and reincorporated as a Delaware corporation on July 21, 2006. Tactile Medical focuses on advancing at-home care for chronic conditions, aiming to improve patient outcomes, quality of life, and control healthcare expenditures. Their therapeutic focus areas include: (1) vascular disease, specifically treating lymphedema and chronic venous insufficiency; (2) oncology, addressing lymphedema as a common consequence for cancer survivors; and (3) providing airway clearance therapy for individuals with chronic respiratory conditions. The company utilizes a scalable platform to deliver at-home healthcare solutions across the United States. For its lymphedema portfolio, Tactile Medical generally employs a direct-to-patient and -provider model. This involves obtaining patient referrals from clinicians, managing insurance claims for patients and clinicians, delivering solutions directly to patients, and training them on proper usage. This model facilitates direct engagement with both patients and clinicians, allowing the company to provide clinical evidence and education.

Tactile Systems Technology, Inc. (NASDAQ:TCMD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 14 items for TCMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-02, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for TCMD spans 10-Q, 8-K, DEF 14A, PRE 14A.

Recent high-impact activity:

  • Tactile Medical 10-Q: Q3 Revenue $91.9M, New COO Named, $75.1M Cash
  • Tactile Systems Posts 31c Q3 EPS as Lymphedema Sales Jump 13%
  • Tactile Medical Q3 Revenue Up 7% to $91.9M, FY26 EBITDA Guidance Raised to $50-52M
  • Tactile Systems Q2 Revenue Beats, But Guidance Narrowed on Airway Clearance Weakness
  • Tactile Medical Lands Exclusive U.S. Rights to ElastiMed's MyoSleeve for VA and DoD Patients

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$329.52M
Net Income
$19.09M
Diluted EPS
$0.82
Op. Cash Flow
$42.81M
Free Cash Flow
$40.43M
Gross Profit
$250.15M
Operating Income
$29.28M
Cash & Equivalents
$83.45M
Total Debt
$0
Debt / Equity
0.00×
Net Margin
5.8%
Shares Outstanding
22.44M sh
Source: 10-K · filed 2026-02-17 · accession 0001104659-26-016380

Short Interest & Short Volume

16.72 days to cover

FINRA reported short interest of 2,788,674 shares in TCMD as of the October 30, 2026 settlement, a 1.4% decrease from the prior period — about 16.7 days to cover at its recent average daily volume. On November 20, 2026, 57.6% of TCMD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,788,674 shares as of October 30, 2026
Change vs prior period▼ 1.4%
Days to cover16.72 at avg daily volume of 166,833
Daily short volume (FINRA facilities)57.6% of 79,137 shares on November 20, 2026
5-day average short volume54.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with T →
$26.09 +0.38% today
52-week range · as of 2026-11-02 $14.84 – $37.77
Market cap
$573.48M
Volume
239.3K (1.1× avg)
3-mo avg 222.1K
Live data · 2026-11-21 12:18 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TCMD - Latest Insights

TCMD
Nov 02, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $22.87
Real-time Price: $26.09 info
Change: +$3.22 (+14%) info
Market Cap: $573.475M info
TCMD
Nov 02, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.87
Real-time Price: $26.09 info
Change: +$3.22 (+14%) info
Market Cap: $573.475M info
TCMD
Nov 02, 2026, 4:04 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.87
Real-time Price: $26.09 info
Change: +$3.22 (+14%) info
Market Cap: $573.475M info
TCMD
Aug 10, 2026, 4:21 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $29.72
Real-time Price: $26.09 info
Change: -$3.63 (-12%) info
Market Cap: $573.475M info
TCMD
Jul 13, 2026, 9:23 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $29.83
Real-time Price: $26.09 info
Change: -$3.74 (-13%) info
Market Cap: $573.475M info
TCMD
Jul 13, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $29.83
Real-time Price: $26.09 info
Change: -$3.74 (-13%) info
Market Cap: $573.475M info
TCMD
May 07, 2026, 5:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.01
Real-time Price: $26.09 info
Change: +$0.080 (+0.31%) info
Market Cap: $573.475M info
TCMD
May 04, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $23.01
Real-time Price: $26.09 info
Change: +$3.08 (+13%) info
Market Cap: $573.475M info
TCMD
May 04, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $23.00
Real-time Price: $26.09 info
Change: +$3.09 (+13%) info
Market Cap: $573.475M info
TCMD
May 04, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $21.50
Real-time Price: $26.09 info
Change: +$4.59 (+21%) info
Market Cap: $573.475M info
TCMD
Mar 25, 2026, 9:00 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $26.50
Real-time Price: $26.09 info
Change: -$0.410 (-2%) info
Market Cap: $573.475M info
TCMD
Mar 10, 2026, 9:01 AM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $28.96
Real-time Price: $26.09 info
Change: -$2.87 (-10%) info
Market Cap: $573.475M info
TCMD
Feb 17, 2026, 4:06 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $33.17
Real-time Price: $26.09 info
Change: -$7.08 (-21%) info
Market Cap: $573.475M info
TCMD
Feb 17, 2026, 4:04 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $30.21
Real-time Price: $26.09 info
Change: -$4.12 (-14%) info
Market Cap: $573.475M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets